AYLA   $0.5036  12.90% Market Closed

Ayala Pharmaceuticals Inc
Total Cash 11.20M
totalCashPerShare 0.783
EBITDA -37.39M
Total Debt 0.00
quickRatio 1.985
currentRatio 2.284
Total Revenue 1.73M
debtToEquity
Revenue/Share 0.113
ROA -0.78207
ROE -1.61849
grossProfits
freeCashflow -19.34M
operatingCashflow -34.13M
earningsGrowth
revenueGrowth -0.854
grossMargins 0.05193
ebitdaMargins 0.0
operatingMargins -21.66301
profitMargins 0.0
enterpriseValue -3.99M
forwardPE -0.23314412
floatShares 6.90M
sharesOutstanding 14.82M
sharesShort 48.23K
sharesShortPriorMonth 148.82K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.30%
heldPercentInstitutions 0.38%
Short Ratio help_outline 1.15%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.907
Price To Book help_outline 0.18
earningsQuarterlyGrowth
netIncomeToCommon -38.47M
trailingEps -2.87%
forwardEps -2.45%
enterpriseToEbitda 0.11
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 4Q 2022
institutionsCount 16
lastUpdated March 16, 2023, 7:24 a.m.